These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2330704)

  • 1. [The role of immunologic factors in the pathogenesis of urolithiasis].
    Ukhal' MI; Drannik GN
    Vrach Delo; 1990 Jan; (1):32-4. PubMed ID: 2330704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk of lithiasis and urolithiasis in children with unspecific inflammatory bowel disease].
    Makosiej R; Czkwianianc E; Niedworok M; Małecka-Panas E
    Pol Merkur Lekarski; 2007 May; 22(131):410-3. PubMed ID: 17679383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The colloidal-crystalline properties of the urine and stone formation].
    Kuryk MV; Tsapenko MV
    Fiziol Zh (1978); 1992; 38(2):73-9. PubMed ID: 1568502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the role of urinary macromolecules in urolithiasis: review of methodologies and a proposal for a standard reference crystallization system.
    Rodgers AL; Jappie D
    Scanning Microsc; 1996; 10(2):535-45; discussion 545-6. PubMed ID: 9813630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The phenomenon of the pathological crystallization of stone-forming urinary salts in urolithiasis].
    Shatokhina SN; Shabalin VN
    Urol Nefrol (Mosk); 1998; (2):16-9. PubMed ID: 9577696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polyoxidonium in the treatment of calculous pyelonephritis].
    Kazeko NI; Zhmurov VA; Borovskiĭ AA; Lerner GIa; Katrenko IV; Nechaĭ EN; Shmelev PA
    Urologiia; 2006; (2):59-62. PubMed ID: 16708592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personal experience in the diagnosis and monitoring of therapy in metabolic disorders with risk of crystallization in patients with recurrent urolithiasis].
    Stejskal D; Bártek J; Hrebícek J; Bána J; Zát'ura F; Mohapl P; Terber R
    Vnitr Lek; 1997 Dec; 43(12):781-6. PubMed ID: 9601889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urolithiasis caused by infection].
    Rodríguez Rebollo T; Torres C; Aguilar J; Arrabal M; López C
    Arch Esp Urol; 1987 May; 40(4):263-7. PubMed ID: 3632053
    [No Abstract]   [Full Text] [Related]  

  • 9. [Unspecific immunity in patients with urolithiasis].
    Roman LI; Gichko II
    Vrach Delo; 1972 Apr; 4():65-7. PubMed ID: 5048957
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathogenesis of the phosphorus and calcium metabolic changes in urolithiasis].
    Timofeev SA
    Urol Nefrol (Mosk); 1980; (3):45-8. PubMed ID: 7385476
    [No Abstract]   [Full Text] [Related]  

  • 11. Excretion of urinary phosphate and magnesium on three diets in patients with urolithiasis.
    Juuti M; Alhava EM; Lammi S
    Ann Clin Res; 1981 Feb; 13(1):1-5. PubMed ID: 7247320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

  • 13. [The clinico-laboratory evaluation of the efficacy of Ciprobai and Cifran in treating the exacerbations of chronic pyelonephritis in patients with urolithiasis].
    Savitskaia KI; Trapeznikova MF; Dutov VV; Nekhorosheva AG; Nasonov VN; Skala LZ
    Urol Nefrol (Mosk); 1994; (3):11-4. PubMed ID: 8079401
    [No Abstract]   [Full Text] [Related]  

  • 14. [The characteristics of calculus formation in the kidneys of patients in families predisposed to urolithiasis].
    Aleksandrov VP; Tiktinskiĭ OL; Novikov IF; Mikhaĭlichenko VV; Gnoian VP
    Urol Nefrol (Mosk); 1993; (4):16-9. PubMed ID: 8310557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Etiology, pathogenesis and treatment of acute pyelonephritis in urolithiasis patients].
    Rubtsov IuS
    Urol Nefrol (Mosk); 1985; (6):26-8. PubMed ID: 4090113
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The characteristics of histocompatibility antigen distribution in urolithiasis patients with a phosphorus metabolic disorder].
    Aleksandrov VP; Skriabin GN
    Urol Nefrol (Mosk); 1993; (2):25-7. PubMed ID: 7941139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urolithiasis].
    Piasecki Z; Wyczółkowski M
    Przegl Lek; 1998; 55(9):485-7. PubMed ID: 10085729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis and diagnosis of urolithiasis in the light of studies on calcium, magnesium and phosphate metabolism as well as on urine surface tension].
    Bocian J; Wochna Z; Pacholuk U
    Pol Przegl Chir; 1969 Aug; 41(8):Suppl 8a:1103+. PubMed ID: 5343558
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.